CDC: Shortage of Key Baby Drug Beyfortus Raises Concern

The Centers for Disease Control and Prevention (CDC) is urging physicians to prioritize the distribution of novel RSV medication, Beyfortus, to the most susceptible infants due to limited availability, reported Axios.[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.